In conclusion, we found that RP11-79H23.3 was downregulated in bladder cancer and could liberate miR-107 via its function as a ceRNA to suppress PTEN expression and activate the PI3K/Akt signaling pathway, which consequently contributes to the pathogenesis and progression of BC. The gene discussed is PTEN; the disease is urinary bladder carcinoma.